Biodesix Inc
BDSXNasdaqCIK 1439725HealthcareFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-08-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-043064 |
| 2021-05-2716:18 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-175320 |
| 2021-05-1116:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026558 |
| 2021-05-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-026542 |
| 2021-04-2916:27 ET | DEF 14A | Proxy statementPeriod 2021-05-26 | 0001193125-21-140545 |
| 2021-03-2316:38 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-014880 |
| 2021-03-1615:01 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-013512 |
| 2021-03-1614:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-013508 |
| 2021-01-0821:28 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-000607 |
| 2021-01-0518:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-000191 |
| 2020-12-1016:31 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-056735 |
| 2020-12-1016:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-314902 |
| 2020-11-0916:30 ET | SC 13D | Ownership report, active investor | 0000905148-20-001190 |
| 2020-10-2617:38 ET | S-1/A | Registration statement, amended | 0001193125-20-275630 |
| 2020-10-2108:43 ET | S-1/A | Registration statement, amended | 0001193125-20-273369 |
| 2020-10-1421:38 ET | S-1/A | Registration statement, amended | 0001193125-20-268763 |
| 2020-10-0912:18 ET | S-1/A | Registration statement, amended | 0001193125-20-266992 |
| 2020-10-0215:32 ET | S-1 | Registration statement | 0001193125-20-262422 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:59 ET. Listed shows no prices and gives no investment advice.